‘Steep Rise’ In Patients Struggling To Get Epilepsy Drugs

Same Difference

There has been a “steep rise” in the number of people struggling to get hold of medication which helps control their seizures, the Epilepsy Society says.

The charity says “anxiety and stress” are putting patients at greater risk of seizures.

It is calling for the government to commission an urgent review of the medicines supply chain.

Although uncertainties around Brexit have highlighted medicine shortages, there has been a problem for years.

Last week the drug company Sanofi said there were shortages of an epilepsy drug, sodium valproate, in some areas because of supply disruption at a factory last year, and not related to Brexit.

The company added that the situation was improving.

A Department of Health and Social Care spokesperson said: “As Sanofi has made clear, these issues are unrelated to our exit from the EU and they have followed the well-established processes we have to manage the small number…

View original post 392 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.